人工肺の世界市場:医療機器パイプライン分析2017

【英語タイトル】Artificial Lung - Medical Devices Pipeline Assessment, 2017

GlobalDataが出版した調査資料(GDME0495EPD)・商品コード:GDME0495EPD
・発行会社(調査会社):GlobalData
・発行日:2017年11月7日
・ページ数:36
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における人工肺の製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・人工肺の概要
・人工肺の開発動向:開発段階別分析
・人工肺の開発動向:セグメント別分析
・人工肺の開発動向:領域別分析
・人工肺の開発動向:規制Path別分析
・人工肺の開発動向:承認日(推定)別分析
・企業別人工肺の開発動向(パイプライン製品、進行中の治験)
・人工肺の最近動向
【レポートの概要】

Artificial Lung – Medical Devices Pipeline Assessment, 2017

Summary

GlobalData’s Medical Devices sector report, “Artificial Lung – Medical Devices Pipeline Assessment, 2017″ provides an overview of Artificial Lung currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Lung pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Artificial Lung under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Lung and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Lung under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Artificial Lung Overview 5
3 Products under Development 6
3.1 Artificial Lung – Pipeline Products by Stage of Development 6
3.2 Artificial Lung – Pipeline Products by Territory 7
3.3 Artificial Lung – Pipeline Products by Regulatory Path 8
3.4 Artificial Lung – Pipeline Products by Estimated Approval Date 9
3.5 Artificial Lung – Ongoing Clinical Trials 10
4 Artificial Lung – Pipeline Products under Development by Companies 11
4.1 Artificial Lung Companies – Pipeline Products by Stage of Development 11
4.2 Artificial Lung – Pipeline Products by Stage of Development 12
5 Artificial Lung Companies and Product Overview 13
5.1 ALung Technologies Inc Company Overview 13
5.1.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Breethe, Inc. Company Overview 17
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Case Western Reserve University Company Overview 18
5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Haemair Ltd Company Overview 19
5.4.1 Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 Lung Biotechnology PBC Company Overview 20
5.5.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 McGowan Institute for Regenerative Medicine Company Overview 21
5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 MedArray Inc. Company Overview 23
5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Michigan Critical Care Consultants, Inc. Company Overview 24
5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 Miromatrix Medical Inc Company Overview 25
5.9.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 The Charles Stark Draper Laboratory Inc Company Overview 26
5.10.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 University of California San Francisco Company Overview 27
5.11.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 University of Pittsburgh Company Overview 28
5.12.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 28
5.13 Xenios AG Company Overview 29
5.13.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 29
6 Artificial Lung- Recent Developments 31
6.1 Sep 27, 2017: ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the US Market 31
6.2 Apr 25, 2017: ALung Submits IDE Application to FDA Seeking Approval to Conduct Pivotal Study of the Hemolung RAS 32
7 Appendix 33
7.1 Methodology 33
7.2 About GlobalData 36
7.3 Contact Us 36
7.4 Disclaimer 36

1.1 List of Tables
Table 1: Artificial Lung - Pipeline Products by Stage of Development 6
Table 2: Artificial Lung - Pipeline Products by Territory 7
Table 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Table 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Table 5: Artificial Lung - Ongoing Clinical Trials 10
Table 6: Artificial Lung Companies - Pipeline Products by Stage of Development 11
Table 7: Artificial Lung - Pipeline Products by Stage of Development 12
Table 8: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: Hemolung RAS - Product Status 13
Table 10: Hemolung RAS - Product Description 13
Table 11: ALung Technologies Inc - Ongoing Clinical Trials Overview 14
Table 12: Hemolung RAS - A Pivotal Clinical Study of Hemolung Respiratory Assist System in Treatment of Patients with Chronic Obstructive Pulmonary Disease 15
Table 13: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support 15
Table 14: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 15
Table 15: Hemolung RAS - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 16
Table 16: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 16
Table 17: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: OXY-1 - Product Status 17
Table 19: OXY-1 - Product Description 17
Table 20: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: Portable Artificial Lung - Product Status 18
Table 22: Portable Artificial Lung - Product Description 18
Table 23: Haemair Ltd Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: Portable Artificial Lung - Product Status 19
Table 25: Portable Artificial Lung - Product Description 19
Table 26: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: Implantable Artificial Lung - Product Status 20
Table 28: Implantable Artificial Lung - Product Description 20
Table 29: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: Biohybrid Artificial Lung - Product Status 21
Table 31: Biohybrid Artificial Lung - Product Description 21
Table 32: Chronic Artificial Lung - Product Status 22
Table 33: Chronic Artificial Lung - Product Description 22
Table 34: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 35: Artificial Lung Fiber - Product Status 23
Table 36: Artificial Lung Fiber - Product Description 23
Table 37: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 38: BioLung - Product Status 24
Table 39: BioLung - Product Description 24
Table 40: Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 41: Miromatrix Artificial Lung - Product Status 25
Table 42: Miromatrix Artificial Lung - Product Description 25
Table 43: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 44: Silicone-Based Microfluidic Artificial Lung - Product Status 26
Table 45: Silicone-Based Microfluidic Artificial Lung - Product Description 26
Table 46: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 27
Table 47: Neonatal ECMO Device - Product Status 27
Table 48: Neonatal ECMO Device - Product Description 27
Table 49: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 28
Table 50: Paracorporeal Ambulatory Assist Lung - Product Status 28
Table 51: Paracorporeal Ambulatory Assist Lung - Product Description 28
Table 52: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 29
Table 53: i-lung - Product Status 29
Table 54: i-lung - Product Description 29
Table 55: Xtralung - Product Status 30
Table 56: Xtralung - Product Description 30
Table 57: Glossary 35

1.2 List of Figures
Figure 1: Artificial Lung - Pipeline Products by Stage of Development 6
Figure 2: Artificial Lung - Pipeline Products by Territory 7
Figure 3: Artificial Lung - Pipeline Products by Regulatory Path 8
Figure 4: Artificial Lung - Pipeline Products by Estimated Approval Date 9
Figure 5: Artificial Lung - Ongoing Clinical Trials 10

【掲載企業】

ALung Technologies Inc
Breethe, Inc.
Case Western Reserve University
Haemair Ltd
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray Inc.
Michigan Critical Care Consultants, Inc.
Miromatrix Medical Inc
The Charles Stark Draper Laboratory Inc
University of California San Francisco
University of Pittsburgh
Xenios AG

【レポートのキーワード】

人工肺

★調査レポート[人工肺の世界市場:医療機器パイプライン分析2017] (コード:GDME0495EPD)販売に関する免責事項を必ずご確認ください。
★調査レポート[人工肺の世界市場:医療機器パイプライン分析2017]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆